- Supported exchanges /
- TWO /
- 6576.TWO
Foresee Pharmaceuticals Co Ltd (6576 TWO) stock market data APIs
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. Foresee Pharmaceuticals Co., Ltd. was incorporated in 2013 and is based in Taipei, Taiwan.
Foresee Pharmaceuticals Co Ltd Financial Data Overview
76.8 | |
77.8 | |
- | |
78 | |
76.6 | |
68.4-107.5 | |
10 441 M | |
136 M | |
327 M | |
-1.21 | |
1.114 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Foresee Pharmaceuticals Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 327 M
- EBITDA -797 665 024
- Earnings Per Share -6.34
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Foresee Pharmaceuticals Co Ltd Earnings via APIs
- Latest Release 2024-08-14
- EPS/Forecast -1.4
Get Foresee Pharmaceuticals Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: